Elligo Health Research Acquires Protenium Clinical Research

Published on: 

Applied Clinical Trials

Elligo Health Research, an integrated research organization, has acquired Protenium Clinical Research, an established research group led by Robert Strzinek, Ph.D., D.O. which conducts pharmaceutical studies in a broad range of therapeutic areas. The acquisition will bring the number of patients in Elligo’s Research Ready network to more than one million.

Read the full release here.